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Primary synovial sarcoma of the prostate is an uncommon malignant tumor. There are few cases reported in the
English medical literature to date. Here, we present a case of 22-year-old man with primary synovial sarcoma of the
prostate metastatic to the liver and lung. To our knowledge, only six reports of synovial sarcoma involving the
prostate have been previously published. We also reviewed the previous treatments and prognoses in previous
case reports and evaluate the proper treatment for this disease.
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Primary synovial sarcomas have been described at un-
usual sites, including the heart, oesophagus, larynx,
pleura, lung, kidney, prostate, liver, abdominal wall,
retroperitoneum and gastrointestinal tract; involvement of
the genitourinary tract is exceedingly rare [1-3]. Synovial
sarcoma arising primarily from the prostate is a rare oc-
currence, with only six previously reported cases. Synovial
sarcoma of the prostate is usually identified at a late stage
because of its nonspecific presentation. The purpose of
our article is to add an additional case to the literature, to
review the literature, and to formulate treatment recom-
mendations. We describe a patient presenting with pri-
mary synovial sarcoma of the prostate metastatic to the
liver and lung.Case presentation
A 22-year-old man presented elsewhere with lower
urinary tract symptoms and was referred to us for further
evaluation because of urinary retention. No particular
family history or occupational hazard was elicited. Our
patient complained of dysuria, urinary frequency and
nocturia five to ten times per night before urinary reten-
tion. On digital rectal examination, a large prostatic
mass was palpable, and the surface was smooth. His* Correspondence: urology@zju.edu.cn
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reproduction in any medium, provided the orserum prostate-specific antigen was 1.2 ng/ml (normal
4 or less). Pelvic computerized tomography (CT) im-
aging (Figure 1) and magnetic resonance imaging (MRI)
(Figure 2) demonstrated a 14-cm mass that appeared to
originate in the prostatic fascia. Another 8.5-cm mass
was found in the right groin area. CT and chest radiog-
raphy showed evidence of liver and lung metastasis
(Figure 3). The patient’s age was younger than the com-
mon age range of patients for the commonest types of
prostatic adenocarcinoma. Ultrasound-guided transrec-
tal needle biopsy and pathologic examination revealed
synovial sarcoma. The pathologic findings were consist-
ent with the diagnosis of synovial sarcoma arising from
the prostate (Figure 4). On immunohistochemical stain-
ing, the tumor cells were positive for vimentin and
CD99, but negative for alpha smooth muscle actin, desmin,
and S-100 protein. The presence of SYT-SSX fusion tran-
script was confirmed by RT-PCR using genomic DNA iso-
lated from paraffin blocks. The patient refused to receive
any therapeutic schedule including irradiation、chemo-
therapy and radical prostatectomy. His disease progression
was rapid. At three months of follow-up, the patient had
developed multiple lung metastases and subsequently died
of respiratory failure.
Discussion
Synovial sarcoma is a clinically and histomorphologically
well-defined soft tissue tumor that is extremely uncom-
mon, with about 90% synovial sarcomas occurring on theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Enhanced pelvic computed tomography. (A) Evidence of liver metastasis. (B-F), Enhanced pelvic computed tomography
revealed a 14-cm mass that appeared to originate in the prostatic fascia. An 8.5-cm mass was found on pelvic magnetic
resonance imaging.
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pulmonary metastases develop after primary tumor sur-
gery. In the urinary system, most synovial sarcomas
have been reported in the kidney [4]. Primary synovial
sarcomas involving the prostate are exceedingly rare,
with only a handful of cases reported in the English
medical literature to date (Table 1) [5,6].
Primary prostatic sarcomas are rare tumors and most
patients present with urinary obstruction, as did our
patient. The pathologic findings were consistent with
the diagnosis of synovial sarcoma arising from the pros-
tate. In common with other synovial sarcomas, theFigure 2 Enhanced pelvic magnetic resonance imaging. (A-C) Enhance
the prostatic fascia and an 8.5-cm mass was found in the right groin area.immunohistochemical staining demonstrated some typ-
ical findings of synovial sarcoma: the tumor cells were
positive for vimentin and CD99, but negative for CD34,
Bcl-2, alpha smooth muscle actin, desmin, and S-100 pro-
tein. Finally, the presence of SYT-SSX fusion transcript
confirmed the diagnosis [7,8].
Several clinicopathologic features were particular for
primary synovial sarcoma of the prostate. As compared
with the most common malignant tumor of the prostate
adenocarcinoma, prostatic sarcoma occurs in relatively
younger patients [9]. According to the previous reports,
the age of diagnosis for these patients was 37 to 63 years.d pelvic T2 weighted MR revealed a high signal mass originating in
Figure 3 Chest radiography. (A) Evidence of lung metastasis.
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this range. Most patients with prostatic sarcoma present
with symptoms of bladder outlet obstruction. Our pa-
tient complained of dysuria, urinary frequency and noc-
turia before urinary retention. The massive tumor may
have been responsible for this symptom. The PSA level
of prostatic adenocarcinoma is often elevated. It has
been reported that the PSA level may not rise in pa-
tients with prostatic sarcoma, due to the non-epithelial
origin of prostate sarcoma [9]. PSA levels in previous
patients with prostatic synovial sarcoma ranged from
0.5 ng/ml to 0.9 ng/ml. Our patient had a PSA level of
1.20 ng/ml, which was still within normal range. Pros-
tatic synovial sarcoma image findings are not well re-
ported. In one case report by Shirakawa, T2 weighted
MRI revealed a high signal mass originating in the pros-
tatic fascia [5]. The imaging findings of primary synovialFigure 4 Pathologic analysis. (A) The pathologic findings of the tumor (H
(C) Immunohistochemical staining for CD99 in tumor tissue.sarcoma of the prostate are not unique and pathologic
examination is the only way to make a definite
diagnosis.
The survival of persons with primary prostatic sar-
comas is poor, with most patients dying within a few
months after diagnosis and surgery. Distant pulmon-
ary metastases are found in most patients with this
disease, whether the patient has undergone surgery
or not. In our case, the tumor had metastasis to the
liver and lung. Treatment for this sarcoma is uncer-
tain due to extremely limited experience but it ap-
pears that aggressive resection has to be considered
for the treatment of locally confined synovial sar-
coma [10]. The role of adjuvant chemotherapy and/
or radiation remains unknown; however, it is strongly
recommended because of the poor prognosis. Docu-
mentation of further cases is needed to establish
appropriate therapy.
Conclusion
In conclusion, we demonstrate a case of primary pros-
tatic synovial sarcoma. Due to the paucity of cases of
synovial sarcoma involving the prostate, protocols for
definitive treatment are not well defined. Treatment
for this tumor is uncertain due to extremely limited
experience, but it appears that aggressive resection
should be considered as the standard therapy. The role
of adjuvant chemotherapy and radiation also remains
unknown. Reporting of future cases is necessary to
establish appropriate therapeutic guidelines for this
disease.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
ages. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.&E). (B) Immunohistochemical staining for vimentin in tumor tissue.
Table 1 Clinicopathologic features, treatment, and prognosis of seven cases of primary synovial sarcoma of prostate
Cases
Iwasaki Shirakawa Williams Pan Li first case Li second case This study
Age (years) 37 52 63 44 46 44 22
Clinical findings Gross hematuria, dysuria,
painful micturition






Dysuria gradually Dysuria, urinary frequency,
nocturia, urinary retention
Serum PSA (ng/ml) None 0.9 0.5 2.91 0.35 1.19 1.2











from the mid-potion of
the prostate inferiorly to










12-cm mass extending to
the bladder, the rectum
and pelvic soft tissue,
partial necrosis
14-cm mass that appeared to
originate in the prostatic fascia.
Another 8.5-cm mass was
found in the right groin area
IHC results VM+, EMA + VM+ VM+, CK(CAM5.2)+, S100
+, CK7+, CKAE1/3+,CAL+
VM+, CD99+, CK +,
bcl-2+
VM+, CD99+, bcl-2



















The tumor could not be
completely resected
None
Prognosis Died (32 months, tumor
recurrence and metastasis
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